11/26
08:28 am
adil
Adial Pharmaceuticals Announces a Warrant Inducement Transaction for Approximately $2.86 Million in Gross Proceeds [Yahoo! Finance]
Low
Report
Adial Pharmaceuticals Announces a Warrant Inducement Transaction for Approximately $2.86 Million in Gross Proceeds [Yahoo! Finance]
11/26
08:00 am
adil
Adial Pharmaceuticals Announces a Warrant Inducement Transaction for Approximately $2.86 Million in Gross Proceeds
Medium
Report
Adial Pharmaceuticals Announces a Warrant Inducement Transaction for Approximately $2.86 Million in Gross Proceeds
11/14
02:03 pm
adil
Adial Pharmaceuticals GAAP EPS of -$0.08 [Seeking Alpha]
Low
Report
Adial Pharmaceuticals GAAP EPS of -$0.08 [Seeking Alpha]
11/14
09:04 am
adil
Adial Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Low
Report
Adial Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
11/14
08:30 am
adil
Adial Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
Low
Report
Adial Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
10/17
09:00 am
adil
Adial Pharmaceuticals CEO was a Featured Guest on The Big Biz Show
Low
Report
Adial Pharmaceuticals CEO was a Featured Guest on The Big Biz Show
10/9
08:30 am
adil
Adial Pharmaceuticals Partners with Genomind for Precision Medicine Testing Solution
Low
Report
Adial Pharmaceuticals Partners with Genomind for Precision Medicine Testing Solution
10/3
02:47 pm
adil
Adial Pharmaceuticals (NASDAQ:ADIL) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Adial Pharmaceuticals (NASDAQ:ADIL) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
9/30
08:38 am
adil
Adial Pharmaceuticals (NASDAQ:ADIL) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $1.50 price target on the stock.
Medium
Report
Adial Pharmaceuticals (NASDAQ:ADIL) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $1.50 price target on the stock.
9/16
08:00 am
adil
Adial Pharmaceuticals Provides Business Update Following Favorable Comments from FDA End-of-Phase 2 (EOP2) Meeting for AD04
High
Report
Adial Pharmaceuticals Provides Business Update Following Favorable Comments from FDA End-of-Phase 2 (EOP2) Meeting for AD04